Paratek Pharmaceuticals, Inc. promoted Christopher Bostrom to Chief Financial Officer. Bostrom joined Paratek in March 2016 and has over 20 years of financial, strategic and operational experience. He is a results-driven financial executive skilled at understanding underlying business drivers to assess current performance and new business opportunities while providing insights for allocating resources to maximize value.

Prior to Paratek?s take-private transaction, Bostrom led the finance function, investor relations, capital restructuring and fundraising efforts for the company. Before joining Paratek, he spent over eight years at Biogen Inc. in global business planning, finance, and accounting roles with scope across corporate finance, commercial operations, R&D and technical operations. Bostrom received his Bachelor of Science in business administration from Stonehill College and an MBA from Babson College.